Partner, Boston Consulting Group · Los Angeles
I help senior leaders across industries, especially in MedTech and BioPharma, set ambitious growth targets and translate them into executable strategy at the intersection of innovation, strategic judgment, and enterprise transformation.
Defining credible long-term ambitions, building muscle for strategic foresight, prioritizing competing options, and building roadmaps that translate aspiration into execution.
Moving from growth ambition to realized, enterprise-level impact through executable programs and initiatives supported by a durable operating model.
Deep expertise across life science tools, diagnostics, genomics, biopharma, medical devices, and health tech, grounded in translational biology research.
I am a Partner at Boston Consulting Group, where I lead engagements in Corporate Finance & Strategy and Health Care. My work focuses on growth strategy, total shareholder return, innovation, and large-scale transformation, primarily with MedTech, BioPharma, and Life Sciences companies.
I am a co-author of BCG's Most Innovative Companies and Vitality reports and bring considerable expertise in digital health, molecular diagnostics, pharmacology, data analytics, deep tech, and commercialization.
Before joining BCG, I was a research fellow in pharmacology at Baylor College of Medicine and a founder and board member of Enventure, a non-profit connecting life science entrepreneurs with educational and networking resources.
I work with CEOs, boards, and senior leadership teams. If you're navigating a complex strategic decision in healthcare or life sciences, I'm glad to connect.